Clinical Trial Update: Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma [Phase 2]

View source ↗

Summary

This entry reports the completion of a Phase 2 trial evaluating cisplatin and S-1 with or without nimotuzumab in untreated advanced gastric adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Nimotuzumab (nimotuzumab)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Stomach Neoplasms | Phase 2 | Status: COMPLETED